Ad

Tag: Zydus Cadila

India Has Enough Stock of Hydroxychloroquine: Govt

(New Delhi)India Has Enough Stock of Hydroxychloroquine: Govt
The government on Friday said that there is enough stock of hydroxychloroquine in the country and it is taking all steps to ensure that there is no shortage of the drug in the domestic market.
India manufactures 70 per cent of the world’s supply of hydroxychloroquine. Companies like IPCA and Zydus Cadila are the major manufacturers of hydroxychloroquine in the country.
The Indian pharmaceutical industry earlier this week said there is enough stock of hydroxychloroquine in the country and drug firms are ready to ramp up the production to meet domestic as well as export requirements.
India currently has an annual installed capacity of around 40 tonnes of active pharmaceutical ingredients (APIs) of hydroxychloroquine. With this capacity, it can make around 200 million tablets of 200 mg, which can be ramped up, the Indian Drug Manufacturers’ Association (IDMA) had said.
India on Tuesday had decided to partially lift the ban on the export of anti-malarial drug hydroxychloroquine in sync with its global commitment to deal with the coronavirus pandemic.